A course jointly organised by the Hepatology and Metabolic Center, Leuven and the Charles Dent Metabolic Unit, London. This course will include up to date, state of the art lectures and debates, with expert European speakers, regarding current evidence for predicting / preventing complications, and treatment, including transplant and its outcomes, in inherited liver disease.
Disorders covered will include the glycogen storage disorders, disorders of glycosylation, lysosomal acid lipase deficiency, disorders of bile acid synthesis, the organic acidemias, Wilson disease and mitochondrial disease. The latest advances in gene therapy and stem cell therapy for metabolic liver disease and the role of circulating microRNAs will also be discussed.
Participants will be encouraged to bring challenging and/or informative cases for discussion.
Learning objectives
- To be aware of the complications associated with inherited disorders of the liver.
- To be aware of up to date evidence on current options for treatment, and their outcomes.
- To consider current and potential future methods of predicting or preventing complications.
Institutes of main organisers - providers
- Hepatology and Metabolic Center, Leuven
- Charles Dent Metabolic Unit, London.
Scientific Organising Committee
- Dr David Cassiman, Leuven
- Dr Elaine Murphy, London
- Dr John Walter, Manchester
Contact RRD Foundation
Cecilia Kellquist
Recordati Rare Diseases Fondation d'entreprise
Immeuble ‘Le Wilson’
70 avenue du Général de Gaulle
92800 PUTEAUX, France
Telephone : +33 1 47 73 86 11
Fax : +33 1 49 00 18 00
Email : ckellquist@rrd-foundation.org